Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
40,805,612
-
Shares change
-
-2,615,891
-
Total reported value, excl. options
-
$360,286,694
-
Value change
-
-$30,324,254
-
Put/Call ratio
-
7.9%
-
Number of buys
-
58
-
Number of sells
-
68
-
Price
-
$8.83
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q3 2018
As of 30 Sep 2018 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,805,612 shares of stock of the company.
Largest 10 holders included BlackRock Inc., Nantahala Capital Management, LLC, Novo Holdings A/S, Vanguard Group Inc, PERCEPTIVE ADVISORS LLC, STATE STREET CORP, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, ABRAMS CAPITAL MANAGEMENT, L.P., and Clearbridge Investments, LLC.
This table shows 126 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.